Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 3Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Respiratory Aspiration 1Pulmonary Atelectasis 1Pneumothorax 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Diseases 1Pericardial Effusion 1Pain, Postoperative 1Mesothelioma, Malignant 1Lung Diseases 1Kidney Neoplasms 1Hemothorax 1Empyema, Pleural 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Arrhythmias, Cardiac 1Acute Pain 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Anesthesia, General × Clear all
NCT04726878 2021-11-09

ESP in Breast Surgery Due to Cancer

Medical University of Lublin

Phase 4 Completed
75 enrolled
Breast

Breast Neoplasms, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡